CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
INNOVHEM is a French start-up focused on developing innovative diagnostic tools for Sickle Cell Disease. By integrating biomarkers with artificial intelligence, the project aims to enhance personalized medical care and improve treatment outcomes for patients, particularly in resource-poor settings.
INNOVHEM is a french start-up that has been incorporated in October 2019 which develops new and relevant diagnostic tools to tackle Sickle cell disease.
Sickle Cell Disease is a very severe disease and is the most frequent genetic disease over the world, affecting around 5 million people.
Despite this disease has been discovered at the beginning of the 20th century, there is still several unmet needs to tackle it.
In resource-poor countries, about 90% of children are estimated to die before the…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 topics.
Guests see up to 5 keywords.
